Concepedia

Andris Elksnis

AE

Statistics

Publications

5

Citations

162

H-Index

5

Active since

2017

Affiliations

Science for Life Laboratory(Current)

Uppsala University

Glucox Biotech (Sweden)

Andris Elksnis is an author at Science for Life Laboratory specializing in beta-cell dysfunction, life sciences, and pharmacology.

ORCID

Publications per year

2017–2021

5

Publications

5

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

Xuan Wang, Andris Elksnis, Per Wikström et al. · PLoS ONE · 2018 · 73 citations · Full text

, , +17

EndoC-βH1 cells display increased sensitivity to sodium palmitate when cultured in DMEM/F12 medium

Camilla Krizhanovskii, Hjalti Kristinsson, Andris Elksnis et al. · Islets · 2017 · 35 citations · Full text

, , +17

GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes

Daniel Espes, Hanna Liljebäck, Henrik Hill et al. · BMJ Open Diabetes Research & Care · 2021 · 30 citations · Full text

, , +17

Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells

Andris Elksnis, Jing Cen, Per Wikström et al. · Biomedicines · 2021 · 13 citations · Full text

, , +17

Endogenous Levels of Gamma Amino-Butyric Acid Are Correlated to Glutamic-Acid Decarboxylase Antibody Levels in Type 1 Diabetes

Henrik Hill, Andris Elksnis, Per Lundkvist et al. · Biomedicines · 2021 · 11 citations · Full text

, , +17

1–5 of 5